Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2026-09-14 18:25:45 ET · period of report 2026-09-10 · accession 0001209181-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 18:25 | 2026-09-10 | ROIV | MOMTAZEE JAMES C | Dir | F - Tax | $40.94 | -2,905 | 106.9K | -3% | -$118.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-10 | F | D | 2,905 | $40.94 | 106,905 | D | — | — | (F1) Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. |